Gilead Sciences Inc.

GILD-Q

NASDAQ:GILD

59.89
0.22 (0.37%)
Gilead Sciences is an American biopharmaceutical company that discovers, develops and commercializes drugs.
More at Wikipedia

Analysis and Opinions about GILD-Q

Signal
Opinion
Expert
BUY
BUY
May 9, 2013

Biotech group has been performing extremely well. There is growth and there is an expectation that they will be bought by a traditional drug company. You are buying something for growth here. Prefers to own the group, such as XBI-N, an ETF.

Show full opinionHide full opinion

Biotech group has been performing extremely well. There is growth and there is an expectation that they will be bought by a traditional drug company. You are buying something for growth here. Prefers to own the group, such as XBI-N, an ETF.

COMMENT
COMMENT
October 2, 2012

Anybody who bought this stock over the past number of years has made a profit because this one is near its historical highs. Company doesn’t interest him because it has done too well. Did a takeover which muddied the balance sheet so it is pretty ugly. Insiders have been selling an awful lot of the company.

Show full opinionHide full opinion

Anybody who bought this stock over the past number of years has made a profit because this one is near its historical highs. Company doesn’t interest him because it has done too well. Did a takeover which muddied the balance sheet so it is pretty ugly. Insiders have been selling an awful lot of the company.

BUY
BUY
February 19, 2009
Likes Bio Pharma and ethical pharmaceutical companies. Good diversity in their product lines. Good underlying growth.
Show full opinionHide full opinion
Likes Bio Pharma and ethical pharmaceutical companies. Good diversity in their product lines. Good underlying growth.
COMMENT
COMMENT
December 1, 2008
Trading down 7.1% on a one-year basis and 20 X forward earnings.
Show full opinionHide full opinion
Trading down 7.1% on a one-year basis and 20 X forward earnings.
Showing 241 to 244 of 244 entries